Form 4 for PAHC PHIBRO ANIMAL HEALTH CORP
Accepted 2026-02-11 00:00:00 ET · period of report 2026-02-09 · accession 0001104659-26-013378 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-02-11 | 2026-02-09 | PAHC | David Glenn | CFO | M - OptEx | — | +30.0K | 64.8K | +86% | — |
| D | 2026-02-11 | 2026-02-11 | PAHC | David Glenn | CFO | J - Other | $51.63 | -12.5K | 52.3K | -19% | -$646.8K |
| D | 2026-02-11 | 2026-02-09 | PAHC | David Glenn | CFO | M - OptEx | $0.00 | -30.0K | 240.0K | -11% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2026-02-09 | M | A | 30,000 | — | 64,845 | D | — | — | (F1) Shares were issued in settlement of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Class A Common Stock. |
| 2 | Common | Class A Common Stock | 2026-02-11 | J | D | 12,528 | $51.63 | 52,317 | D | — | — | (F2) Represents shares sold in a broker assisted cashless exercise program to satisfy tax withholding obligations upon the receipt of Class A Common Stock in connection with the vesting and settlement of the RSUs. (F3) The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.54 to $52.03. The reporting person undertakes to provide to Phibro Animal Health Corporation (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 3 | Derivative | Restricted Stock Units | 2026-02-09 | M | D | 30,000 | $0.00 | 240,000 | D | — · — to — | 30,000 Class A Common Stock | (F1) Shares were issued in settlement of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Class A Common Stock. (F4) On February 9, 2024 (the "Grant Date"), the reporting person was granted 300,000 RSUs pursuant to the Issuer's 2008 Incentive Plan and an RSU award agreement (the "Award Agreement"). (F5) Pursuant to the Award Agreement, (i) 150,000 RSUs are subject to time vesting (collectively, the "Time Vesting RSUs") and vest in equal installments on each of the first five anniversaries of the Grant Date, subject to continued service through each such vesting date, and (ii) 150,000 RSUs are subject to performance vesting (collectively, the "Performance Vesting RSUs") and vest (with linear interpolation to apply for achievement between increments) based upon achievement of the arithmetic average of the Issuer's closing stock price per share for each trading day in the 90-calendar day period ending five years from the Grant Date, from $20 to $60 and above, subject to Mr. David's continued employment on such date. Time Vesting RSUs and Performance Vesting RSUs, in each case, are subject to earlier vesting upon certain qualifying termination events. |